SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-023797
Filing Date
2020-09-01
Accepted
2020-09-01 20:33:23
Documents
2
Period of Report
2020-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3787
2 EX-24 DOCUMENT attachment1.htm EX-24 5371
  Complete submission text file 0000899243-20-023797.txt   10512
Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
FAMBROUGH DOUGLAS (Reporting) CIK: 0001259856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 201155517

Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations